|
Volumn 64, Issue , 2013, Pages 42-53
|
Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation
|
Author keywords
Antiplatelet; Arachidonic acid; Carboxamide; Pyrazole
|
Indexed keywords
1 [[1 (6 METHOXYPYRIDAZINE 3 YL) 5 (4 CHLOROPHENYL) 1H PYRAZOLE 3 YL]CARBONYL] 4 (4 FLUOROPHENYL)PIPERAZINE;
1 [[1 (6 METHOXYPYRIDAZINE 3 YL) 5 (4 CHLOROPHENYL) 1H PYRAZOLE 3 YL]CARBONYL] 4 (4 METHYLPHENYL)PIPERAZINE;
1 [[1 (6 METHOXYPYRIDAZINE 3 YL) 5 (4 CHLOROPHENYL) 1H PYRAZOLE 3 YL]CARBONYL] 4 (5 TRIFLUOROMETHYLPYRIDINE 2 YL)PIPERAZINE;
1 [[1 (6 METHOXYPYRIDAZINE 3 YL) 5 (4 CHLOROPHENYL) 1H PYRAZOLE 3 YL]CARBONYL]PIPERIDINE;
1[[1 (6 METHOXYPYRIDAZINE 3 YL) 5 (4 CHLOROPHENYL) 1H PYRAZOLE 3 YL]CARBONYL] 4 (PYRIMIDINE 2 YL)PIPERAZINE;
2 CHLOROPYRIDIN 3 YL 5 (4 CHLOROPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
3 ISOPROPYLPHENYL 5 (4 CHLOROPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
3 METHYLBUTYL 5 (4 CHLOROPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
4 (1H IMIDAZOL 1 YL)PHENYL 5 (4 CHLOROPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
4 [[1 (6 METHOXYPYRIDAZINE 3 YL) 5 (4 CHLOROPHENYL) 1H PYRAZOLE 3 YL]CARBONYL]MORPHOLIN;
4 CYCLOPENTYLPHENYL 5 (4 CHLOROPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
4 METHOXYPHENYL 5 (4 CHLOROPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
4 METHYLPHENYL 5 (4 CHLOROPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
4 PROPOXYPHENYL 5 (4 CHLOROPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
5 (4 CHLOROPHENYL) 1 (6 CHLOROPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLIC ACID;
5 (4 CHLOROPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) N (PYRIDIN 4 YL) 1H PYRAZOLE 3 CARBOXAMIDE;
5 (4 CHLOROPHENYL) 1 (6 OXO 1,6 DIHYDROPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLIC ACID;
5 (4 CHLOROPHENYL) N (4 METHOXYPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXAMIDE;
6 [5 (4 CHLOROPHENYL) 3 (PIPERIDINE 1 CARBONYL) 1H PYRAZOL 1 YL]PYRIDAZIN 3(2H) ONE;
[5 (4 CHLOROPHENYL) 1 [6 (METHYLSULFONYL)PYRIDAZIN 3 YL)] 1H PYRAZOL 3 YL](MORPHOLINO)METHANONE;
[5 (4 CHLOROPHENYL) 1 [6 (METHYLSULFONYL)PYRIDAZIN 3 YL)] 1H PYRAZOL 3 YL](PIPERIDIN 1 YL)METHANONE;
AMIDE;
ANTITHROMBOCYTIC AGENT;
ARACHIDONIC ACID;
ETHYL 5 (4 CHLOROPHENYL) 1 (6 CHLOROPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
METHYL 5 (4 CHLOROPHENYL) 1 (6 CHLOROPYRIDAZINE 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
N,5 BIS(4 CHLOROPHENYL) 1 (6 METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBPXAMIDE;
NAPHTHALEN 2 YL 5 (4 CHLOROPHENYL) 1 (6-METHOXYPYRIDAZIN 3 YL) 1H PYRAZOLE 3 CARBOXYLATE;
PYRAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ARTICLE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
STRUCTURE ACTIVITY RELATION;
THROMBOCYTE AGGREGATION;
ARACHIDONIC ACID;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
PYRAZOLES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84877086675
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2013.03.048 Document Type: Article |
Times cited : (22)
|
References (33)
|